股票简称：信凯科技 股票代码：001335 浙江信凯科技集团股份有限公司 Trust Chem Co., Ltd. （浙江省杭州市余杭区仓前街道东莲街 1069 号 2 幢，3 幢 1-3 层） 首次公开发行股票并在主板上市 之 上市公告书 保荐人（主承销商） （深圳市福田区福田街道福华一路 119 号安信金融大厦） 二零二五年四月 浙江信凯科技集团股份有限公司 上市公告书 特别提示 浙江信凯科技集团股份有限公司（以下简称"信凯科技"、"本公司"、"公 司"或"发行人"）股票将于2025年4月15日在深圳证券交易所主板上市。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素，在新 股上市初期切忌盲目跟风"炒新"，应当审慎决策、理性投资。 如无特别说明，本上市公告书中的简称或名词释义与《浙江信凯科技集团股 份有限公司首次公开发行股票并在主板上市招股说明书》中的相同。如本上市公 告书中合计数与各加数直接相加之和在尾数上存在差异，系由于四舍五入所致。 1 浙江信凯科技集团股份有限公司 上市公告书 第一节 重要声明与提示 一、重要声明 本公司及全体董事、监事、高级管理人员保证上市公告书的真实性、准确性、 ...

浙江信凯科技集团股份有限公司 首次公开发行股票并在主板上市之 上市公告书提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 经深圳证券交易所审核同意，浙江信凯科技集团股份有限公司（以下简称"本 公司"、"发行人"、"信凯科技"）发行的人民币普通股股票将于2025年4月 15日在深圳证券交易所主板上市，上市公告书全文和首次公开发行股票并在主板 上市招股说明书全文披露于中国证监会指定的信息披露网站：巨潮资讯网 （ www.cninfo.com.cn ） 、 中 国 证 券 网 （ www.cnstock.com ）、证券日报网 （www.zqrb.cn）、证券时报网（www.stcn.com）、中证网（www.cs.com.cn）、 经济参考网（www.jjckb.cn）、中国金融新闻网（www.financialnews.com.cn）、 中国日报网（www.chinadaily.com.cn），供投资者查阅。 1、股票简称：信凯科技 2、股票代码：001335 3、本次公开发行后的总股本：93,739,560股 4、本次公开发行的股票数量：23,434 ...

中国杭州市钱江新城新业路 8 号 UDC 时代大厦 A 座 5-8 层、12 层、23 层 Floors5-8,12and23,Block A,UDC Times Building,No.8 Xinye Road，Qianjiang New City,Hangzhou Tel.0571-88879999 Fax.0571-88879000 www.zhcpa.cn 公中目有材业许可的会计师事务 您可使用手机"扫一扫"或进入"注册 台 (http://acc. t.gov.cn 报告编码:浙25MJ192GVI 内部控制审计报告 中汇会审[2025]3705号 浙江信凯科技集团股份有限公司全体股东: 浙江信凯科技集团股份有限公司 内部控制审计报告 我们认为,信凯科技公司于2024年12月31日按照《企业内部控制基本规范》 和相关规定在所有重大方面保持了有效的财务报告内部控制。 中国杭州市钱江新城新业路 8 号 UDC 时代大厦 A 座 5-8 层、12 层、23 层 Floors5-8,12and23,Block A,UDC Times Building,No.8 Xinye Road, Qianjiang N ...

浙江信凯科技集团股份有限公司 2024 年度内部控制评价报告 浙江信凯科技集团股份有限公司全体股东: 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求(以下简称 企业内部控制规范体系),结合浙江信凯科技集团股份有限公司(以下简称"公司"或"本公 司")内部控制制度和评价办法,在内部控制日常监督和专项监督的基础上,我们对公司2024 年12月31日(内部控制评价报告基准目)的内部控制有效性进行了评价。 三、内部控制评价工作情况 一、重要声明 按照企业内部控制规范体系的规定,建立健全和有效实施内部控制,评价其有效性,并如 实披露内部控制评价报告是公司董事会的责任。监事会对董事会建立和实施内部控制进行监 督。经理层负责组织领导企业内部控制的日常运行。公司董事会、监事会及董事、监事、高级 管理人员保证本报告内容不存在任何虚假记载、误导性陈述或重大遗漏,并对报告内容的真实 性、准确性和完整性承担个别及连带法律责任。 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及相关信息真实 完整,提高经营效率和效果,促进实现发展战略。由于内部控制存在的固有局限性,故仅能为 实现上述目标提供合理保 ...

国投证券股份有限公司 关于浙江信凯科技集团股份有限公司 首次公开发行股票并在主板上市 之 上市保荐书 二〇二五年四月 保荐机构（主承销商） | 目 录 1 | | --- | | 一、发行人基本情况 3 | | 二、本次证券发行情况 12 | | 三、保荐机构是否存在可能影响公正履行保荐职责情形的说明 15 | | 四、保荐机构承诺事项 15 | | 五、发行人就本次证券发行上市履行的相关决策程序 16 | | 六、保荐机构关于发行人符合板块定位及国家产业政策的核查情况 17 | | 七、保荐机构关于发行人是否符合《上市规则》规定的上市条件的说明 19 | | 八、保荐机构对发行人证券上市后持续督导工作的具体安排 24 | | 九、保荐机构对本次证券发行上市的推荐结论 25 | 深圳证券交易所： 国投证券股份有限公司（以下简称"国投证券"、"保荐机构"、"本保荐 机构"）接受浙江信凯科技集团股份有限公司（以下简称"信凯科技"、"发行 人"、"公司"）的委托，就其首次公开发行股票并在主板上市事项（以下简称 "本次发行"）出具本上市保荐书。 国投证券及其保荐代表人根据《中华人民共和国公司法》（以下简称"《公 司法 ...

上海市锦天城律师事务所 关于浙江信凯科技集团股份有限公司 首次公开发行股票并在深圳证券交易所主板上市的 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 11/12 层 电话：021-20511000 传真：021-20511999 邮编：200120 | 一、 | 本次发行上市的批准和授权 3 | | --- | --- | | 二、 | 发行人具备本次发行上市的主体资格 4 | | 三、 | 发行人符合本次发行上市的实质条件 4 | | 四、 | 本次发行上市的保荐机构和保荐代表人 5 | | 五、 | 发行人及相关责任主体出具的承诺及约束措施 6 | | 六、 | 结论意见 6 | 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于浙江信凯科技集团股份有限公司 首次公开发行股票并在深圳证券交易所主板上市的 为出具本法律意见书，本所律师作如下声明： 1．本所及本所律师依据本法律意见书出具日以前已经发生或者存在的事实， 严格履行了法定职责，遵循了勤勉尽责和诚实信用原则，进行了充分的核查验证， 保证本法律意见书所认定的事实真实、准确、完整，所发表的结论性意见合法、 准确，不存在虚 ...

Group 1: Company Overview - Taihe Co., Ltd. (301665.SZ) is primarily engaged in the research, production, and sales of pesticide products and functional chemicals, holding a leading position in the industry with key products such as Bacillus subtilis, pyraclostrobin, and 2,4-D [1][3] - The company has established long-term strategic partnerships with multinational corporations such as Syngenta, Dow, and Honeywell, and exports to major markets including South America, North America, Southeast Asia, and Europe [3][4] - The company ranked 19th, 22nd, 21st, and 25th in the list of top 100 pesticide sales companies in China from 2021 to 2024 according to the China Pesticide Industry Association [2] Group 2: Financial Information - The issue price for Taihe Co., Ltd. is set at 10.27 CNY per share, with an institutional offering price of 10.68 CNY per share, and a market capitalization of 4.159 billion CNY [2] - The company plans to use 8.96 billion CNY (85.76%) of the raised funds for a fungicide project and 1.49 billion CNY (14.24%) for a research and development center project [2] - The company reported overseas sales revenues of 2.801 billion CNY, 4.549 billion CNY, 2.946 billion CNY, and 1.454 billion CNY from 2021 to June 2024, accounting for 78.42%, 89.58%, 77.10%, and 74.43% of total revenue respectively [3] Group 3: Market Position and Competitors - The company has a dynamic price-to-earnings ratio of 13.40, with comparable companies such as Lier Chemical at 33.12 and Yangnong Chemical at 18.15 [2] - The company’s main raw materials include various chemicals such as xylene, phenol, and liquid ammonia, sourced from suppliers like Anhui Guangxin Agricultural Chemical Co., Ltd. and Zhejiang Hengdian Puluo Import and Export Co., Ltd. [3] Group 4: Risk Factors - The company has indicated that changes in export tax rebate policies for pesticide products could impact sales costs and gross profit margins [4] Group 5: Company Overview (Xinkai Technology) - Xinkai Technology (001335.SZ) specializes in the development, quality management, supply chain integration, and global sales of organic pigments and other coloring agents [4][5] - The company has been ranked first in the organic pigment export industry in China from 2015 to 2023 according to the China Dye Industry Association [7] - Xinkai Technology has established long-term partnerships with major international companies such as DIC Corporation and AkzoNobel, enhancing its brand influence in the industry [8] Group 6: Financial Information (Xinkai Technology) - The issue price for Xinkai Technology is set at 12.80 CNY per share, with an institutional offering price of 14.45 CNY per share, and a market capitalization of 900 million CNY [5] - The company plans to allocate 1.65 billion CNY (62.21%) of the raised funds for the construction of a research and development center and headquarters, and 1.00 billion CNY (37.79%) for repaying bank loans [7] Group 7: Market Position and Competitors (Xinkai Technology) - The company collaborates with large, stable suppliers to ensure supply stability, maintaining a safety stock of 1-2 months for major products [8][9] - The actual controllers of Xinkai Technology, Li Zhi and Li Wu, hold a combined 97% of the company's shares prior to the issuance, which is expected to remain at 72.75% post-issuance [9]

Core Viewpoint - Xinkai Technology (001335.SZ) has initiated its subscription with an issue price of 12.80 yuan per share and a price-to-earnings ratio of 14.38 times, focusing on the development, sales, and service of organic pigments and colorants [1][2]. Company Overview - Xinkai Technology specializes in organic pigments, including azo pigments, heterocyclic pigments, and phthalocyanine pigments, primarily used in inks, coatings, and plastics [1]. - The company has established subsidiaries in countries such as the Netherlands, the USA, Australia, Canada, Turkey, India, and the UK, with operations in over 70 countries and regions [2]. Market Position - Xinkai Technology is a leading exporter in the organic pigment industry in China, having ranked first in exports from 2015 to 2023 according to the China Dye Industry Association [2]. - The company has completed 89 REACH registrations for organic pigments and related chemicals, positioning itself as a leader in the domestic market for REACH compliance [2]. Financial Performance - The company reported revenues of approximately 1.206 billion yuan, 1.192 billion yuan, 1.069 billion yuan, and 666 million yuan for the years 2021, 2022, 2023, and the first half of 2024, respectively [2]. - Net profits for the same periods were 89.06 million yuan, 85.31 million yuan, 84.55 million yuan, and 42.49 million yuan [2]. - As of June 30, 2024, total assets amounted to 1.629 billion yuan, with equity attributable to shareholders at 597.35 million yuan and a debt-to-asset ratio of 60.68% [3].

Company Overview - Xinkai Technology, established in 1996, is a significant supplier in the global organic pigment industry, focusing on the development, sales, and service of organic pigments and colorants [2][4] - The company offers over 450 specifications of pigment products, including azo pigments, heterocyclic pigments, and phthalocyanine pigments, which are known for their durability and environmental friendliness [2][4] Financial Performance - In 2024, Xinkai Technology achieved a revenue of approximately 1.417 billion yuan, representing a year-on-year increase of 32.55%, and a net profit of about 111 million yuan, up 26.31% [5] - The revenue growth is attributed to stable macroeconomic conditions and increased consumer confidence, leading to higher downstream demand [5] - For Q1 2025, the company expects revenue between 340 million to 370 million yuan, reflecting a year-on-year growth of 6.94% to 16.37%, and a net profit of 20.5 million to 23.5 million yuan, indicating a growth of 18.23% to 35.53% [5] Market Position - Xinkai Technology has been the top exporter of organic pigments in China for several consecutive years, with a significant presence in over 70 countries and regions [6][7] - The company has established long-term partnerships with major international firms, enhancing its brand influence in the industry [7] Industry Insights - The global organic pigment market maintains a balanced demand and supply, with an annual production of approximately 400,000 to 500,000 tons, and China being the largest producer and exporter [7][8] - In 2022, the global organic pigment market size was approximately 368.62 million yuan, with Xinkai Technology's sales amounting to 1.145 billion yuan, capturing about 3.11% of the market share [8] - The industry is expected to see increased competitiveness and profitability for leading companies like Xinkai Technology due to rising environmental regulations and industry upgrades [8]